Biogen Inc. buy Haans
Start price
24.10.16
/
50%
€261.98
Target price
24.04.17
€288.64
Performance (%)
3.34%
End price
24.04.17
€250.39
Summary
This prediction ended on 24.04.17 with a price of €250.39. The BUY prediction by Haans finished with a performance of 3.34%. Haans has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 5.009% | 5.009% | 4.594% | -45.624% |
| iShares Core DAX® | -0.121% | 2.507% | 16.129% | 61.530% |
| iShares Nasdaq 100 | 0.081% | -0.241% | 4.636% | 97.770% |
| iShares Nikkei 225® | -1.748% | 4.105% | 16.103% | 48.713% |
| iShares S&P 500 | -0.961% | -0.143% | 1.644% | 62.430% |
Comments by Haans for this prediction
In the thread Biogen Inc. diskutieren
Biotech muss man nicht haben, aber man sollte...
Das Aufwärtsgap , von Ende Juli, wurde geschlossen, jetzt kann es wieder Richtung Norden gehen.
(Laufzeit überschritten)